Showing results (481-490 of 497) with videos related to

Sort By:
Pageof 50
Health Research Policy and Systems|June 16, 2019
Impact of using a broad-based multi-institutional approach to build capacity for non-communicable disease research in ThailandKathleen Potempa, Benjaporn Rajataramya, Debra L Barton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 23, 2015
Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney TransplantationR K Batra, R L Heilman, M L Smith, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Antifungal rapamycin analogues with reduced immunosuppressive activityD A Dickman, H Ding, Q Li, et al.
Journal of Consulting and Clinical Psychology|June 1, 1997
Evidence that therapy works in clinically representative conditionsW R Shadish, G E Matt, A M Navarro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)Deirdre R Pachman, Rui Qin, Drew K Seisler, et al.
Epilepsy & Behavior : E&B|August 21, 2015
The relevance of neuropsychiatric symptoms and cognitive problems in new-onset epilepsy - Current knowledge and understandingB Pohlmann-Eden, A Aldenkamp, G A Baker, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506)Y W Chen, M L Smith, M P Sheets, et al.
The Journal of Biological Chemistry|October 11, 2001
Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compoundsJ M Trevillyan, X G Chiou, Y W Chen, et al.
Cell Death and Differentiation|January 6, 2007
Bcl-2 family proteins are essential for platelet survivalH Zhang, P M Nimmer, S K Tahir, et al.
The Journal of Investigative Dermatology|May 8, 1999
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Pageof 50